United Kingdom · 
Who invested in Rinri Therapeutics?
Rinri Therapeutics's investors include Boehringer Ingelheim Venture Fund, UCB Ventures, Innovate UK, The Future Fund and BioCity.
20202021
$1.9MSeed$4.5MGrant
United Kingdom · Funded startup
Who invested in Rinri Therapeutics
Funding summaryUpdated 26 Oct 2026
$6.4Mraised across 2 rounds since 2019, from 2 sources
$1.9MSeed$4.5MGrant
- Latest round
- Grant, $4.5MMay 2021
- Step-upi
- 2.4×
- Investors
- 5 (2 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $1.9M May 2019
- Biggest round
- $4.5M Grant · May 2021
- Between rounds
- 23 months from the last two
The rounds
- May 2021Grant$4.5M2 new1 returning
Source recorded
- May 2019
Founders and team
From Rinri Therapeutics's own website: 1 founder, 18 on the team.
Professor Marcelo RivoltaFounder and Chief Scientific Officer
- Dr. Simon ChandlerChief Executive Officer
- Rachel HainesVice President, Clinical Development & Operations
- Dr. Terri GaskellChief Technology Officer
- Professor Doug HartleyChief Medical Officer
- Sophie PriceClinical Operations Coordinator
- Ben StephensDirector of Finance
- Cherith Campbell-BellDirector of Clinical Development
- Daniela CacciabueResearch Associate and University Teacher
- David HipkissIndependent Chair
- Dr. Andre VarciannaResearch Associate
- Dr. Aurelien BungaSenior Scientist
- Dr. Faizah MushtaqClinical Manager
- Dr. Maryam ShariatzadehSenior Scientist
- Oula El-AtatResearch Associate
- Romain RussoData Protection Officer (DPO)
- Sarah SampsonClinical Operations Manager
- Tom LavertyResearch Associate
- William SherlockSenior Scientist
AdvisersRivolta Laboratory
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Boehringer Ingelheim Venture FundCorporate VC2rounds, led 1
BioCityno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rinri Therapeutics
How much has Rinri Therapeutics raised?
Rinri Therapeutics has raised $6.4M across 2 rounds since 2019.
When did Rinri Therapeutics last raise?
Rinri Therapeutics's most recent round was a Grant of $4.5M in May 2021.
What was Rinri Therapeutics's biggest round?
Its most recent round, $4.5M in May 2021, is also its largest on record.
Who backed Rinri Therapeutics first?
Rinri Therapeutics's first round on record, in May 2019, was backed by Boehringer Ingelheim Venture Fund, UCB Ventures and BioCity.
What stage is Rinri Therapeutics at?
Rinri Therapeutics's latest named round is a Grant, in May 2021.
Where is Rinri Therapeutics based?
Rinri Therapeutics is based in the United Kingdom.
Who led Rinri Therapeutics's rounds?
Boehringer Ingelheim Venture Fund led the Seed in 2019.
Companies like Rinri Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.